跳至主要内容
临床试验/CTRI/2017/12/010891
CTRI/2017/12/010891已完成未知

A Comparison of Efficacy of Isotretinoin with that of Methotrexate in Moderate to Severe Chronic Plaque Psoriasis

one0 个研究点目标入组 43 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
one
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients having >10% of body surface area involved by psoriasis and no psoriatic arthritis.
  • 2.Patients having moderate-to-severe chronic plaque psoriasis (defined by a score of at least 6 on the Psoriasis Area-and-Severity Index (PASI).
  • 3.Patients not on any form of systemic antipsoriatic treatment for at least 4 weeks and/or topical treatment for at least 2 weeks prior to the initiation of therapy.

排除标准

  • 1.Patients less than 18 years of age.
  • 2.Pregnant and / or lactating females.
  • 3.Patients noncompliant with an effective regimen of contraception.
  • 4.Patients having hepatic or renal impairment, deranged lipid profile, hematologic impairment, any acute infection requiring antimicrobial therapy, uncontrolled hypertension or diabetes mellitus, with BMI >30 or known psychiatric illness.
  • 5.Patients having a history of cancer, including skin cancer or hematologic, cerebral or pulmonary neoplasia.
  • 6.Patients who were alcoholic or had a long history of alcohol intake.

研究者

发起方
one

相似试验

Weekly methotrexate versus daily isotretinoin to... | 临床试验